California mandate to lower C-sections will impact population health – how can analytics help?

Following a surge of cesarean section (C-section) operations for expecting mothers, doctors in California must now reduce the number of C-sections performed to 23.9 percent for low-risk births. The state’s health insurance marketplace under the Affordable Care Act, Covered California, wants to curb this rate to improve patient safety and quality. Any hospital that doesn’t meet these metrics runs the risk of being removed from the state’s health insurance marketplace as an in-network provider. Currently, most hospitals in California deliver around 40 percent of their babies via C-section.

The medical rationale for reducing the rate of C-sections is strong. C-sections can expose a woman to unnecessary risks such as infection, hemorrhage or even death. Studies also show babies born by C-section have a higher risk of complications and spending more time in the neonatal intensive care unit. We talked to Bruce Carver, Associate Vice President of payer services at MedeAnalytics, about this new mandate and how data analytics can be leveraged to address it.

How could this approach impact hospitals in California?

There are some factors that would be beneficial for Covered California to keep in mind. Reaching the goal ultimately falls on the provider, who is giving patients that care. But hospitals should be examined on a case by case basis if they are not meeting the metric, because removing them from the insurance marketplace could have a huge impact on providers and members, especially in rural areas. 1.4 million people in California purchase their health insurance through 11 insurers on the state exchange. Additionally, there could be valid, uncontrollable reasons why a hospital might miss the metric. But, of the 243 maternity hospitals in the state, 40 percent have already met this target.

How can analytics play a role?

Analytics can ensure health plans are appropriately enforcing such utilization management requirements. For example, they can analyze if the problem exists with a certain market or provider. The real problem is not actually tracking these initiatives, but figuring out what action will illicit the desired outcome. Additionally, health plans are always at risk of losing member utilization through a third party contracting entity that could offer a lower price than the health plan itself. In this circumstance, the health plan does not have knowledge of such services or utilization.

How can Covered California achieve its goal?

To be successful, Covered California should allow data to drive the best decision to achieve the desired outcome, in this case, lowering the C-section rate to 23.9 percent. Over time, analytics can provide the retrospective insight to develop more predictive models that address cost and utilization issues before they have a significant impact on costs. Getting ahead of these issues early can often keep organizations from having to put out these mandates in the first place to correct the market.

MedeAnalytics can help your plan get control of its population health by using data analytics to communicate gaps in care to physicians and improve care coordination. Visit our Population Health page here to learn more, or contact us here.

MedeAnalytics

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.

Leave a Comment





Get our take on industry trends

Providers: Are you ready to be audited?

February 15, 2022

By Donna Kennedy In 2020, regular audits conducted by CMS and other payers were paused or significantly reduced as the…

Read on...

From Insights to Action – The Digital Transformation of Healthcare in the Post-Pandemic “New Normal”

February 10, 2022

In November, MedeAnalytics hosted the 2021 Impact Summit, an engaging and educational event held annually and designed exclusively for our…

Read on...
From Insights to Action – The Digital Transformation of Healthcare in the Post-Pandemic “New Normal”

2022 Rx: Your new, post-pandemic prescription for success

January 11, 2022

By Dave Schweppe, Chief Analytics Officer, MedeAnalytics Despite the common use of the term “post-COVID,” most leaders across the healthcare…

Read on...
Combating the opioid epidemic photo

Combating the opioid epidemic in North America with Nobel Prize winning research

October 12, 2021

American Researchers Dr. David Julius and Dr. Ardem Patapoutian from California were awarded the Nobel Prize in medicine for their path breaking work on the development of non-opioid painkillers, showing immense promise for combating the epidemic.

Read on...